Literature DB >> 4886647

Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus.

J Baum, M Ziff.   

Abstract

The antibody response to immunization with Brucella and the levels of natural antibody to Escherichia coli and Shigella were compared in patients with systemic lupus erythematosus and control groups. After Brucella immunization, SLE patients showed a significantly lower antibody response in whole serum and in the macroglobulin antibody fraction separated by sucrose density gradient centrifugation. Sucrose gradient fractionation of natural antibodies to E. coli and a polyvalent Shigella antigen showed a significant decrease in macroglobulin antibody against four of the five E. coli antigens tested and the Shigella polyvalent antigen in SLE patients when compared with a group of normal individuals and a matched control group with pulmonary tuberculosis. Whole serum natural antibody titers against 5 of 13 Shigella antigens were significantly lower in the SLE patients when compared with the normal group, and against 7 of 13 when compared with the matched tuberculosis controls. Whole serum titers against 8 of 13 E. coli antigens were significantly lower in the SLE patients when compared with normal subjects. The observed decreased antibody response to bacterial antigens in SLE patients, occurring mainly in the macroglobulin fraction, is discussed in relation to the increased incidence of infection commonly observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4886647      PMCID: PMC322280          DOI: 10.1172/JCI106033

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  QUALITATIVE AND QUANTITATIVE IMMUNOGLOBULIN DEFICIENCY.

Authors:  C GILBERT; R HONG
Journal:  Am J Med       Date:  1964-10       Impact factor: 4.965

2.  GAMMA-2, GAMMA-1A AND GAMMA-1M ANTINUCLEAR FACTORS IN HUMAN SERA.

Authors:  E V BARNETT; J J CONDEMI; J P LEDDY; J H VAUGHAN
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

3.  Systemic lupus erythematosus and normal antibodies.

Authors:  L H MUSCHEL
Journal:  Proc Soc Exp Biol Med       Date:  1961-03

4.  [Congenital immunological paresis in the absence of specific beta 2-globulin & normal quantities of gamma-globulin].

Authors:  A GIEDION; J J SCHEIDEGGER
Journal:  Helv Paediatr Acta       Date:  1957-08

5.  Quantitative antibody studies in man. I. The effect of adrenal insufficiency and of cortisone on the level of circulating antibodies.

Authors:  D L LARSON; L J TOMLINSON
Journal:  J Clin Invest       Date:  1951-12       Impact factor: 14.808

6.  Autoantibodies in ulcerative colitis.

Authors:  A R McGiven; T Ghose; R C Nairn
Journal:  Br Med J       Date:  1967-04-01

7.  Antibodies in human brucellosis.

Authors:  J D Coghlan; D M Weir
Journal:  Br Med J       Date:  1967-04-29

8.  Serum levels of immune globulins in health and disease: a survey.

Authors:  E R Stiehm; H H Fudenberg
Journal:  Pediatrics       Date:  1966-05       Impact factor: 7.124

9.  The course of systemic lupus erythematosus.

Authors:  R R Carpenter; B C Sturgill
Journal:  J Chronic Dis       Date:  1966-02

10.  THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT GAMMA M- AND GAMMA G-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES.

Authors:  J B ROBBINS; K KENNY; E SUTER
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  L Turner-Stokes; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

2.  Neutrophil chemotaxis in systemic lupus erythematosus.

Authors:  R A Clark; H R Kimball; J L Decker
Journal:  Ann Rheum Dis       Date:  1974-03       Impact factor: 19.103

3.  Measurement of antibody-producing capacity to flagellin in man. IV. Studies in autoimmune disease, allergy and after azathioprine treatment.

Authors:  A K Lee; I R Mackay; M J Rowley; C Y Yap
Journal:  Clin Exp Immunol       Date:  1971-10       Impact factor: 4.330

4.  Increased 7S antibody response to sheep erythrocytes in the 2-month-old NZB mouse.

Authors:  J Baum
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

5.  Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen.

Authors:  A B Gottlieb; R G Lahita; N Chiorazzi; H G Kunkel
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

6.  Tuberculosis in patients with systemic lupus erythematosus.

Authors:  P H Feng; T H Tan
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

7.  Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone.

Authors:  W T Butler; R D Rossen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

8.  The actual survival rate in systemic lupus erythematosus: study of a 1976 cohort.

Authors:  M Breban; O Meyer; P Bourgeois; E Palazzo; M F Kahn
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

9.  Defective B cell function in systemic lupus erythematosus.

Authors:  B K Pelton; A M Denman
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

10.  Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  P A Neighbour; A I Grayzel
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.